Sensorium Therapeutics
Jonathan Knight has a diverse work experience starting from their internship at Southern Hunt Club LLC in 2015. Jonathan then worked as an FP&A Analyst Intern at TruGreen for two consecutive years in 2016 and 2017. In 2018, Jonathan joined Indigo and held various roles including Corporate Development, Commercial Strategy, and Marketplace Offer until 2022. Jonathan then moved to Alvea as a Strategy & Operations professional for a year until 2023. Currently, Jonathan is working as a Senior Manager of Finance at Sensorium Therapeutics.
Jonathan Knight attended Mississippi State University from 2014 to 2018, earning a Bachelor of Business Administration degree with a focus on Finance and Economics.
This person is not in any offices
Sensorium Therapeutics
Founded by world-class researchers, clinicians, and thought leaders from Massachusetts General Hospital and Harvard University, Sensorium Therapeutics is a biotechnology company leveraging cutting-edge chemistry, neuroscience, and machine learning to develop nature-derived psychoactive medicines for mental health. Inspired by the real-world human benefits of plants and fungi, Sensorium’s groundbreaking Biodynamic Discovery Platform leverages cutting-edge chemistry, neuroscience, and machine learning to reproduce, adapt, and enhance targeted molecules to elevate their utility as modern medicines that can deliver transformational benefits to patients around the world.